about
Posttraumatic stress disorder in medically ill patients: what is known, what needs to be determined, and why is it important?Posttraumatic stress disorder: a missed link between psychiatric and cardiovascular morbidity?Age at diagnosis, gender, and metabolic control in children with type 1 diabetes.Racial and economic disparities in transplant outcomes: the not-so-hidden morbidities.The adolescent transplant recipient.Adherence to medical recommendations and transition to adult services in pediatric transplant recipients.Does poor early metabolic control predict subsequent poor control in young children with type 1 diabetes: an exploratory study.A randomized controlled trial of the safety and promise of cognitive-behavioral therapy using imaginal exposure in patients with posttraumatic stress disorder resulting from cardiovascular illness.Brief report: Deficits in health care management skills among adolescent and young adult liver transplant recipients transitioning to adult care settings.Screening for depression and suicidality in patients with cardiovascular illnesses.Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.Evaluating non-adherence to immunosuppressant medications in pediatric liver transplant recipients.Pilot study: fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer.Childhood abuse, nonadherence, and medical outcome in pediatric liver transplant recipients.Recruiting a representative sample in adherence research-The MALT multisite prospective cohort study experience.Asthma: The past, future, environment, and costs.The Medication Level Variability Index (MLVI) Predicts Poor Liver Transplant Outcomes: A Prospective Multi-Site Study.A systematic review of immunosuppressant adherence interventions in transplant recipients: Decoding the streetlight effect.Prospective analysis of nonadherence in autoimmune hepatitis: a common problem.Assessment and management of psychosocial challenges in pediatric liver transplantation.Pediatric emergency department assessment of psychological trauma and posttraumatic stress.Assessment and treatment of depression in medically ill childrenAssessment of posttraumatic stress symptoms in children who are medically ill and children presenting to a child trauma programAdherence and medical outcomes in pediatric liver transplant recipients who transition to adult servicesAssessment of depression in medically ill children presenting to pediatric specialty clinicsMeasuring adherence to medications: are complex methods superior to simple ones?Measuring adherence in TORDIATackling the spectrum of transition: what can be done in pediatric settings?Weekend versus weekday adherence: Do we, or do we not, thank God it's Friday?A learning health network for pediatric liver transplantation: Inaugural meeting report from the Starzl Network for Excellence in Pediatric TransplantationPerceived barriers to medication adherence remain stable following solid organ transplantationThe impact of caregiver post-traumatic stress and depressive symptoms on pediatric transplant outcomesParents and clinicians underestimate distress and depression in children who had a transplant
P50
Q36415265-0CA3EF7A-847A-4E2D-A14F-4739AF945DB8Q36415279-B773F279-05C0-4A94-B3DD-BDFBC3A578A0Q37259696-1B8E45C0-E593-4F5D-9DE8-6555A5203351Q37494283-09A8FC72-96A4-443C-AFFD-C7D1FA21AB22Q37725222-545E38BD-BE2C-4999-9363-E9A260A342E1Q37743119-D000039D-6E34-4FA6-A4A6-70DDD19B773AQ37877790-6E848568-53D3-4973-BB5C-C64473B48171Q38373799-BBB0D584-CB9B-498F-BC35-DDFD347CA11AQ39921143-BF774898-A905-4BBD-AA3D-C22BD25E1279Q44612618-99EEA82A-AC02-4B6B-BF3C-59AC55208D07Q46390308-DA822D0D-3333-41B4-9C1A-76BC94AC5114Q46709633-E920F537-C46F-40F0-A843-CAF66DEF2E91Q46807977-91E642AE-A473-4D40-8D61-821DB56B8149Q46988929-F2C9A456-CB33-4A6B-B996-8050AF48FD89Q47912625-B9DDD473-79BD-4D5C-9549-AC50D0254415Q48048793-520AD9FA-6806-4F09-A3A6-42451DB3A1BAQ48099618-C2081482-638E-466F-BD49-388C4A38A66DQ48154811-9E8DECDE-D72D-4A12-A322-3423C6584BF0Q51100139-64C5B156-11DD-4877-8EC6-2A2FCD6ADA04Q51887045-27ABC79F-0927-44BA-BF2C-6D9D3B0FE8CCQ51946923-719F5D76-FDA7-4F7B-A54B-3CB4E86778FCQ77821803-3DA0A4E0-7C34-482D-A6A2-FD4F4A42F35FQ80065536-B60B0A75-D335-43D9-9B41-EADF860752C2Q80702536-462E47CA-340D-4B4B-80CA-8317F4AEF2AAQ81488659-6DC26A68-8A7A-4D83-A387-232229782416Q83752817-C9707A88-46F0-4F6E-BEBE-3978BCB5CBD7Q85022787-FD5B99AB-9000-45D2-A92B-B359A28EEA54Q85194459-8FF25027-D9E2-4AC0-9EB4-EF36EAF97642Q90613106-568E5863-22B3-4D1E-B17C-42528C7B1F3BQ92066607-89417299-1006-42D5-BDE0-007F545FA281Q92100308-7CFAF7B2-6B0C-42F5-85FD-83D16786923EQ92273669-F4C704BB-5179-4236-ABCC-4530EA393C76Q94459831-58D5FE90-4AA2-4585-AD4F-8270D8AA54F9
P50
description
researcher
@en
wetenschapper
@nl
name
Eyal Shemesh
@en
Eyal Shemesh
@nl
type
label
Eyal Shemesh
@en
Eyal Shemesh
@nl
prefLabel
Eyal Shemesh
@en
Eyal Shemesh
@nl
P106
P31
P496
0000-0003-2508-3423